102 related articles for article (PubMed ID: 2732342)
1. Whole blood procoagulant activity in breast and colorectal cancer.
Mellor H; Taylor I; Roath S; Francis JL
J Clin Pathol; 1989 May; 42(5):489-94. PubMed ID: 2732342
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant activity in whole blood from patients with breast and colorectal cancer.
Parmar J; Taylor I; Roath S; Francis J
Blood Coagul Fibrinolysis; 1990 Jun; 1(2):127-32. PubMed ID: 2130924
[TBL] [Abstract][Full Text] [Related]
3. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
4. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
Iversen LH; Okholm M; Thorlacius-Ussing O
Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
[TBL] [Abstract][Full Text] [Related]
5. Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease.
Iversen LH; Thorlacius-Ussing O; Okholm M
Thromb Res; 1995 Sep; 79(5-6):471-81. PubMed ID: 7502273
[TBL] [Abstract][Full Text] [Related]
6. Recalcification time in breast disease.
Sofia CA; Spillert CR; Pastena JA; Lazaro EJ
J Natl Med Assoc; 1988 Nov; 80(11):1214-6. PubMed ID: 3249326
[TBL] [Abstract][Full Text] [Related]
7. The significance of measuring monocyte tissue factor activity in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
Br J Cancer; 1999 Apr; 80(1-2):279-85. PubMed ID: 10390009
[TBL] [Abstract][Full Text] [Related]
8. Assessment of monocyte function in breast disease.
Spillert CR; Curtis GT; Lazaro EJ
South Med J; 1988 Feb; 81(2):164-6. PubMed ID: 3277286
[TBL] [Abstract][Full Text] [Related]
9. Determination of tumor cell procoagulant activity by Sonoclot analysis in whole blood.
Amirkhosravi A; Biggerstaff JP; Warnes G; Francis DA; Francis JL
Thromb Res; 1996 Dec; 84(5):323-32. PubMed ID: 8948059
[TBL] [Abstract][Full Text] [Related]
10. Shortened endotoxin-activated clotting times in patients with carcinoma.
Spillert CR; Lazaro EJ
Am Surg; 1987 Mar; 53(3):164-6. PubMed ID: 3548512
[TBL] [Abstract][Full Text] [Related]
11. Copper, zinc and superoxide dismutase in precancerous, benign diseases and gastric, colorectal and breast cancer.
Magálová T; Bella V; Brtková A; Beno I; Kudlácková M; Volkovová K
Neoplasma; 1999; 46(2):100-4. PubMed ID: 10466433
[TBL] [Abstract][Full Text] [Related]
12. Serum sHLA-G levels: a useful indicator in distinguishing colorectal cancer from benign colorectal diseases.
Zhu CB; Wang CX; Zhang X; Zhang J; Li W
Int J Cancer; 2011 Feb; 128(3):617-22. PubMed ID: 20473865
[TBL] [Abstract][Full Text] [Related]
13. An assessment of monocyte procoagulant activity in patients with solid tumors.
Dasmahapatra KS; Cheung NK; Spillert C; Lazaro E
J Surg Res; 1987 Aug; 43(2):158-63. PubMed ID: 3626537
[TBL] [Abstract][Full Text] [Related]
14. Urinary tissue factor levels in patients with breast and colorectal cancer.
Lwaleed BA; Chisholm M; Francis JL
J Pathol; 1999 Feb; 187(3):291-4. PubMed ID: 10398081
[TBL] [Abstract][Full Text] [Related]
15. Monocyte procoagulant activity in breast cancer.
Auger MJ; Mackie MJ
Thromb Res; 1987 Jul; 47(1):77-84. PubMed ID: 3660345
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.
Henry MM; Moore JN
Circ Shock; 1988 Nov; 26(3):297-309. PubMed ID: 3208423
[TBL] [Abstract][Full Text] [Related]
17. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the monocyte to thrombotic potential.
Spillert CR; Lazaro EJ
Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
[TBL] [Abstract][Full Text] [Related]
20. Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.
Szczepański M; Bardadin K; Zawadzki J; Pypno W
J Cancer Res Clin Oncol; 1988; 114(5):519-22. PubMed ID: 3182913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
